Cargando…

Soliris to Stop Immune-Mediated Death in COVID-19 (SOLID-C19)—A Compassionate-Use Study of Terminal Complement Blockade in Critically Ill Patients with COVID-19-Related Adult Respiratory Distress Syndrome

Eculizumab, a terminal complement (C5)-inhibiting monoclonal antibody, was administered in five mechanically ventilated patients in life-threatening condition due to COVID-19-related acute respiratory distress syndrome (ARDS) between 23 March 2020 and 3 April 2020. Their clinical progress was monito...

Descripción completa

Detalles Bibliográficos
Autor principal:	Pitts, Thomas C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704457/ https://www.ncbi.nlm.nih.gov/pubmed/34960699 http://dx.doi.org/10.3390/v13122429

Ejemplares similares

The use of the complement inhibitor eculizumab (Soliris®) for treating Korean patients with paroxysmal nocturnal hemoglobinuria
por: Kim, Jin Seok, et al.
Publicado: (2010)

COVID-19 and the reimaging of compassionate release
por: James, Jennifer E., et al.
Publicado: (2022)

Compassionate use of remdesivir in children with COVID-19
por: Méndez-Echevarría, Ana, et al.
Publicado: (2020)

Mesenchymal Stem Cells for the Compassionate Treatment of Severe Acute Respiratory Distress Syndrome Due to COVID 19
por: Iglesias, Martin, et al.
Publicado: (2021)

How do we sustain compassionate healthcare? Compassionate leadership in the time of the COVID-19 pandemic
por: de Zulueta, Paquita
Publicado: (2021)

Immune monitoring of interleukin-7 compassionate use in a critically ill COVID-19 patient
por: Monneret, Guillaume, et al.
Publicado: (2020)

Compassionate Use of Remdesivir for Patients with Severe Covid-19
por: Grein, Jonathan, et al.
Publicado: (2020)

The Importance of Compassionate Care during the COVID-19 Pandemic
por: Ghafourifard, Mansour
Publicado: (2021)

Complement dysregulation is associated with severe COVID-19 illness
por: Yu, Jia, et al.
Publicado: (2021)

The Rise and Fall of Chloroquine/Hydroxychloroquine as Compassionate Therapy of COVID-19
por: Manivannan, Elangovan, et al.
Publicado: (2021)

Complement Inhibition in Severe COVID-19 Acute Respiratory Distress Syndrome
por: Raghunandan, Sharmila, et al.
Publicado: (2020)

Multiple drugs: COVID-19 pneumonia and compassionate use of clazakizumab for COVID-19 pneumonia: case report
Publicado: (2020)

Compassionate use of others’ immunity — understanding gut microbiome in Covid-19
por: Thalanayar Muthukrishnan, Prashanth, et al.
Publicado: (2020)

Allogeneic cardiosphere-derived cells (CAP-1002) in critically ill COVID-19 patients: compassionate-use case series
por: Singh, Siddharth, et al.
Publicado: (2020)

CARDIOVASCULAR DISEASE AND OUTCOMES IN CRITICALLY ILL PATIENTS WITH COVID-19: A STOP-COVID ANCILLARY
por: Meloche, Chelsea, et al.
Publicado: (2021)

We Need Compassionate Leadership Management Based on Evidence to Defeat COVID-19
por: Binagwaho, Agnes
Publicado: (2020)

The Impact of Compassionate Connected Care on Safety, Quality, and Experience in the Age of COVID-19
por: Dempsey, Christina
Publicado: (2021)

A case of COVID-19 Convalescent Plasma Donation in Greece: Directed donation for compassionate use in the donor's critically ill father
por: Vlachogianni, Glykeria, et al.
Publicado: (2020)

Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome
por: van de Veerdonk, Frank L, et al.
Publicado: (2020)

Kidney Recovery and Death in Critically Ill Patients With COVID-19–Associated Acute Kidney Injury Treated With Dialysis: The STOP-COVID Cohort Study
por: Hsu, Caroline M., et al.
Publicado: (2022)

Will Peptides Help to Stop COVID-19?
por: Krut’, Viktoriya G., et al.
Publicado: (2022)

High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine
por: McNamara, Lucy A., et al.
Publicado: (2017)

COVID: Its compassionate use
por: Bennett, Jasmiry
Publicado: (2020)

Complement control for COVID-19
por: Bosmann, Markus
Publicado: (2021)

The state of complement in COVID-19
por: Afzali, Behdad, et al.
Publicado: (2021)

Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009
por: Rojek, Amanda M., et al.
Publicado: (2020)

Compassionate drug use: an imperative challenge for Bulgarian health system during COVID-19
por: Dzhafer, Nigyar, et al.
Publicado: (2020)

Providing Compassionate Care: The Role of Medical Students and Videoconference Technology in the COVID-19 Pandemic
por: Suresh, Deepika, et al.
Publicado: (2020)

Remdesivir Prescription in Pregnant Women Infected with COVID-19: A Report of Compassionate Use
por: Zafarbakhsh, Azam, et al.
Publicado: (2023)

Compassionate Use of GC5131 (Hyperimmunoglobulin) Therapy in Critically Ill Patients Diagnosed with COVID-19: A Case Series and Review of Literature
por: Choi, Sunha, et al.
Publicado: (2021)

Successful use of mild therapeutic hypothermia as compassionate treatment for severe refractory hypoxemia in COVID-19
por: Cruces, Pablo, et al.
Publicado: (2021)

Increasing Use of Compassionate Use/Managed Access Channels to Obtain Medicines for Use in COVID‐19
por: Aliu, Paul, et al.
Publicado: (2020)

Experiences and Perceived Origins of Compassionate Ageism Among Older Adults During the COVID-19 Pandemic
por: Ju, Catherine, et al.
Publicado: (2021)

Complement Activation during Critical Illness: Current Findings and an Outlook in the Era of COVID-19
por: Bosmann, Markus
Publicado: (2020)

Targeting complement activation in COVID-19
por: Kulkarni, Hrishikesh S., et al.
Publicado: (2020)

Rationale for targeting complement in COVID‐19
por: Polycarpou, Anastasia, et al.
Publicado: (2020)

Complement as a target in COVID-19?
por: Risitano, Antonio M., et al.
Publicado: (2020)

Curb complement to cure COVID-19
por: Satyam, Abhigyan, et al.
Publicado: (2020)

Editorial: Complement and COVID-19 Disease
por: Prohászka, Zoltán, et al.
Publicado: (2022)

In-Use Stability of SB12 (Eculizumab, Soliris Biosimilar) Diluted in Saline and Dextrose Infusion Solution after an Extended Storage Period
por: Tak, Minji, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ub17o4bhdhbhbu2b3rahq9fg2a